EGFR inhibitors prolong survival in non-small-cell lung cancer

A new meta-analysis shows their superiority over chemotherapy

Adjunct targeted molecular therapy may prolong disease-free survival in patients with resected non-small cell lung cancer harbouring epidermal growth factor receptor mutations, a meta-analysis suggests.